Purpose: People with hematologic malignancies have a significantly higher risk of developing severe and protracted forms of SARS-CoV-2 infection compared to immunocompetent patients, regardless of vaccination status. Results: We describe two cases of prolonged SARS-CoV-2 infection with multiple relapses of COVID-19 pneumonia in patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab. The aim is to highlight the complexity of SARS-CoV-2 infection in this fragile group of patients and the necessity of evidence-based strategies to treat them properly. Conclusions: Patients with hematological malignancies treated with bendamustine and anti-CD20 antibodies had a significant risk of prolonged and relapsing course of COVID-19. Specific preventive and therapeutic strategies should be developed for this group of patients.

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab / Franceschini, Erica; Pellegrino, Mariachiara; Todisco, Vera; Dolci, Giovanni; Bettelli, Francesca; Meschiari, Marianna; Bedini, Andrea; Fregni-Serpini, Giulia; Grottola, Antonella; Guaraldi, Giovanni; Pecorari, Monica; Sarti, Mario; Luppi, Mario; Perno, Carlo Federico; Mussini, Cristina. - In: INFECTION. - ISSN 0300-8126. - 51:5(2023), pp. 1577-1581. [10.1007/s15010-023-02039-2]

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab

Franceschini, Erica;Pellegrino, Mariachiara;Todisco, Vera;Dolci, Giovanni;Bettelli, Francesca;Meschiari, Marianna;Grottola, Antonella;Guaraldi, Giovanni;Luppi, Mario;Mussini, Cristina
2023

Abstract

Purpose: People with hematologic malignancies have a significantly higher risk of developing severe and protracted forms of SARS-CoV-2 infection compared to immunocompetent patients, regardless of vaccination status. Results: We describe two cases of prolonged SARS-CoV-2 infection with multiple relapses of COVID-19 pneumonia in patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab. The aim is to highlight the complexity of SARS-CoV-2 infection in this fragile group of patients and the necessity of evidence-based strategies to treat them properly. Conclusions: Patients with hematological malignancies treated with bendamustine and anti-CD20 antibodies had a significant risk of prolonged and relapsing course of COVID-19. Specific preventive and therapeutic strategies should be developed for this group of patients.
2023
51
5
1577
1581
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab / Franceschini, Erica; Pellegrino, Mariachiara; Todisco, Vera; Dolci, Giovanni; Bettelli, Francesca; Meschiari, Marianna; Bedini, Andrea; Fregni-Serpini, Giulia; Grottola, Antonella; Guaraldi, Giovanni; Pecorari, Monica; Sarti, Mario; Luppi, Mario; Perno, Carlo Federico; Mussini, Cristina. - In: INFECTION. - ISSN 0300-8126. - 51:5(2023), pp. 1577-1581. [10.1007/s15010-023-02039-2]
Franceschini, Erica; Pellegrino, Mariachiara; Todisco, Vera; Dolci, Giovanni; Bettelli, Francesca; Meschiari, Marianna; Bedini, Andrea; Fregni-Serpini...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1302546
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 10
social impact